Immunic appoints Glenn Whaley as CFO and extends Executive Chairman Duane Nash's term to Dec 2022

IMMUNIC, INC.

Glenn Whaley appointed CFO effective March 10, 2022; received option grant for 40,000 shares (25% vest March 10, 2023, remainder monthly).
Duane Nash's Executive Chairman agreement extended to December 31, 2022; base salary $29,358/month.
Nash receives one-time option grant for 75,000 shares, vesting monthly from April 10, 2022.
Both option exercise prices set at closing price on board approval date.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Glenn Whaley

Chief Financial Officer

IMUX · IMMUNIC, INC.

Effective: 2022-03-10
Filed: March 16, 2022, 7:59 PM ET

On March 10, 2022, Glenn Whaley was appointed Chief Financial Officer ("CFO") of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Glenn Whaley was appointed as Chief Financial Officer at IMMUNIC, INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On March 10, 2022, Glenn Whaley was appointed Chief Financial Officer ("CFO") of the Company.

View on SEC.gov

IMMUNIC, INC. filing history →

Source: SEC EDGAR

accession 0001193805-22-000504

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.